Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvanted H1N1 vaccine in healthy Japanese adults
NCT00996138Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adjuvanted cell-derived inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine in influenza, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
adjuvanted cell-derived inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00996138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996138.